← Return to Clinical Trials for Neuropathy
DiscussionClinical Trials for Neuropathy
Neuropathy | Last Active: Oct 5 5:03pm | Replies (22)Comment receiving replies
Replies to "Any information on new CIDP Study using Dual-Target CAR-T Cell Therapy"
← Return to Clinical Trials for Neuropathy
DiscussionClinical Trials for Neuropathy
Neuropathy | Last Active: Oct 5 5:03pm | Replies (22)
@nbailey7uh2edu3 - Have you seen these articles?
-- BCMA-CD19 bispecific CAR-T therapy in refractory chronic inflammatory demyelinating polyneuropathy: https://www.sciencedirect.com/science/article/pii/S2949928324000440
-- CIDP study explores dual-target CAR-T cell therapy for the treatment of relapsed/refractory autoimmune disorders: https://medicalxpress.com/news/2024-06-cidp-explores-dual-car-cell.html